Tumor Lysis Syndrome Following Endoscopic Retrograde Cholangiopancreatography With Stent Placement in a Patient With Cholangiocarcinoma: A Case Report

Tumor lysis syndrome (TLS) is an oncological emergency commonly associated with hematologic malignancies and aggressive chemotherapy. Its occurrence following endoscopic retrograde cholangiopancreatography (ERCP) with stent placement in patients with cholangiocarcinoma is exceedingly rare, with only a handful of cases reported in the literature. This report discusses a unique case of TLS occurring after ERCP in a patient with cholangiocarcinoma, highlighting the clinical challenges and the need for heightened awareness among clinicians. Herein, we present the case of a 58-year-old female patient with a diagnosis of cholangiocarcinoma who developed TLS following ERCP with stent placement. The patient initially underwent the procedure to relieve biliary obstruction, a common palliative intervention in cholangiocarcinoma cases. Within 24 hours post-procedure, the patient exhibited signs of acute renal failure, hyperkalemia, hyperphosphatemia, and hypocalcemia, consistent with TLS. Prompt recognition and aggressive management, including hydration, electrolyte correction, and renal support, were crucial in stabilizing the patient. Despite prompt recognition and aggressive management, including hydration, electrolyte correction, and renal support, the patient unfortunately passed away 24 hours later. This tragic outcome underscores the critical importance of early recognition and intervention, as well as the need for awareness of this rare but possible complication. This case highlights the rare but serious risk of TLS following ERCP in patients with cholangiocarcinoma. Clinicians should be aware of this potential complication, especially in patients with a high tumor burden or those undergoing palliative procedures. Early recognition and intervention are paramount in improving patient outcomes. Further studies are needed to better understand the mechanisms and predisposing factors for TLS in this context.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-02-22
DOI
https://doi.org/10.7759/cureus.79476
Primary Topic
Methemoglobinemia and Tumor Lysis Syndrome
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tumor Lysis Syndrome Following Endoscopic Retrograde Cholangiopancreatography With Stent Placement in a Patient With Cholangiocarcinoma: A Case Report

Rim A Boutari, Fatmeh I Mallah, Mahmoud M Hallal
Cureus
Methemoglobinemia and Tumor Lysis Syndrome
article

Tumor Lysis Syndrome Following Endoscopic Retrograde Cholangiopancreatography With Stent Placement in a Patient With Cholangiocarcinoma: A Case Report

Rim A Boutari, Fatmeh I Mallah, Mahmoud M Hallal
article en

Abstract

Tumor lysis syndrome (TLS) is an oncological emergency commonly associated with hematologic malignancies and aggressive chemotherapy. Its occurrence following endoscopic retrograde cholangiopancreatography (ERCP) with stent placement in patients with cholangiocarcinoma is exceedingly rare, with only a handful of cases reported in the literature. This report discusses a unique case of TLS occurring after ERCP in a patient with cholangiocarcinoma, highlighting the clinical challenges and the need for heightened awareness among clinicians. Herein, we present the case of a 58-year-old female patient with a diagnosis of cholangiocarcinoma who developed TLS following ERCP with stent placement. The patient initially underwent the procedure to relieve biliary obstruction, a common palliative intervention in cholangiocarcinoma cases. Within 24 hours post-procedure, the patient exhibited signs of acute renal failure, hyperkalemia, hyperphosphatemia, and hypocalcemia, consistent with TLS. Prompt recognition and aggressive management, including hydration, electrolyte correction, and renal support, were crucial in stabilizing the patient. Despite prompt recognition and aggressive management, including hydration, electrolyte correction, and renal support, the patient unfortunately passed away 24 hours later. This tragic outcome underscores the critical importance of early recognition and intervention, as well as the need for awareness of this rare but possible complication. This case highlights the rare but serious risk of TLS following ERCP in patients with cholangiocarcinoma. Clinicians should be aware of this potential complication, especially in patients with a high tumor burden or those undergoing palliative procedures. Early recognition and intervention are paramount in improving patient outcomes. Further studies are needed to better understand the mechanisms and predisposing factors for TLS in this context.

CureusVol. 17(2)
Lebanese University (LB), University Medical Center Rizk Hospital (LB)
Good health and well-being
Openalex Percentile: Top 95%
Methemoglobinemia and Tumor Lysis Syndrome
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.